Prevention and Control of Methicillin-Resistant Staphylococcus aureus in Acute Care Settings
|Published in||Infectious Disease Clinics of North America. 2016, vol. 30, no. 4, p. 931-952|
|Abstract||Methicillin-resistant Staphylococcus aureus (MRSA) is a leading cause of health care-associated infections worldwide. Controversies with regard to the effectiveness of various MRSA control strategies have contributed to varying approaches to the control of this pathogen in different settings. However, new evidence from large-scale studies has emerged, particularly with regards to MRSA screening and decolonization strategies, which will inform future control practices. The implementation as well as outcomes of control measures in the real world is not only influenced by scientific evidence but also depends on economic, administrative, governmental, and political influences.|
|Keywords||Anti-Bacterial Agents/administration & dosage/therapeutic use — Cross Infection/prevention & control — Environmental Microbiology — Humans — Infection Control — Methicillin-Resistant Staphylococcus aureus — Staphylococcal Infections/prevention & control|
This document has no fulltext available yet, but you can contact its author by using the form below.
|Research group||Groupe Harbarth Stephan (Staphylocoques dorés résistants à la méthicilline) (866)|
|LEE, Andie S, HUTTNER, Benedikt, HARBARTH, Stéphan Juergen. Prevention and Control of Methicillin-Resistant Staphylococcus aureus in Acute Care Settings. In: Infectious Disease Clinics of North America, 2016, vol. 30, n° 4, p. 931-952. doi: 10.1016/j.idc.2016.07.006 https://archive-ouverte.unige.ch/unige:100423|